Filing Flows › CorMedix (CRMD) › Q1 2025
CorMedix (CRMD) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 6, 2025
CorMedix (CRMD) reported revenue of $39.1M for the first quarter 2025 (Q1 2025) and +25% from the quarter before. Operating margin was 51.5%, net earnings $20.6M (52.8% of revenue).
CorMedix, Q1 2025: revenue $39.1M, operating margin 51.5%, net earnings $20.6M, operating cash flow $19.7M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $39.1M | +25% | — |
| Gross profit | $37.5M | +25% | — |
| Operating profit | $20.1M | +56% | — |
| Net earnings | $20.6M | +53% | — |
| Operating cash flow | $19.7M | — | — |
| Free cash flow | $19.7M | — | — |
What changed
Revenue was $39.1M in Q1 2025, up 25% from the previous quarter.
Gross margin was 95.9%. Operating profit was $20.1M, a 51.5% margin. Net earnings were $20.6M. The effective tax rate was 0.0%.
Operating cash flow was $19.7M, 96% of net earnings. Non-cash charges added back $162K of depreciation and amortization and $3.5M of share-based compensation. Working capital and other items used $4.6M. Capital expenditures of $10K left free cash flow of $19.7M.
Questions
What was CorMedix's revenue in the first quarter 2025?
CorMedix (CRMD) reported revenue of $39.1M for the first quarter 2025 (Q1 2025) and +25% from the quarter before.
Was CorMedix profitable in the first quarter 2025?
Operating profit was $20.1M (51.5% of revenue) and net earnings $20.6M.
Source: CorMedix 10-Q on SEC EDGAR.